HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern

被引：0
|
作者：
Perron, Marjorie [1 ]
Wen, Hannah [1 ]
Hanna, Matthew [1 ]
Brogi, Edi [1 ,2 ]
Ross, Dara [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York, NY USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
241
引用
收藏
页码：235 / 237
页数：3
相关论文
共 50 条
  • [31] INVASIVE MICROPAPILLARY CARCINOMA OF THE BREAST
    SIRIAUNKGUL, S
    TAVASSOLI, FA
    MODERN PATHOLOGY, 1993, 6 (06) : 660 - 662
  • [32] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Morsberger, Laura
    Pallavajjala, Aparna
    Long, Patty
    Hardy, Melanie
    Park, Rebecca
    Parish, Rebecca
    Nozari, Azin
    Zou, Ying S.
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [33] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Laura Morsberger
    Aparna Pallavajjala
    Patty Long
    Melanie Hardy
    Rebecca Park
    Rebecca Parish
    Azin Nozari
    Ying S. Zou
    Cancer Cell International, 22
  • [34] Her2 Expression in Urothelial Carcinoma with Micropapillary Morphology: Preferential Overexpresssion by the Micropapillary Component
    Huang, H.
    Jadallah, S.
    Chen, Y-B
    Gopalan, A.
    Fine, S. W.
    Tickoo, S. K.
    Iyer, G. V.
    Dalbagni, G.
    Solit, D.
    Reuter, V. E.
    Al-Ahmadie, H. A.
    LABORATORY INVESTIGATION, 2013, 93 : 219A - 219A
  • [35] HER2 immunohistochemistry inter-observer reproducibility in 205 cases of invasive breast carcinoma additionally tested by ISH
    Castera, Carlos
    Bernet, Laia
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 45
  • [36] Should a borderline negative HER2 result in a core biopsy of invasive carcinoma of the breast have HER2 assessment repeated in the excision specimen?
    Lee, Andrew H. S.
    Hodi, Zsolt
    Abbas, Areeg
    Wencyk, Peter
    Ellis, Ian O.
    Rakha, Emad
    JOURNAL OF CLINICAL PATHOLOGY, 2024, 77 (11) : 726 - 729
  • [37] Percentage of HER2 immunohistochemistry complete membrane staining is not significantly associated with response to neoadjuvant therapy in HER2 positive breast cancer
    Li, Xiaoxian
    Zhao, Jing
    Zhang, Chao
    Li, Zaibo
    LABORATORY INVESTIGATION, 2019, 99
  • [38] Percentage of HER2 immunohistochemistry complete membrane staining is not significantly associated with response to neoadjuvant therapy in HER2 positive breast cancer
    Li, Xiaoxian
    Zhao, Jing
    Zhang, Chao
    Li, Zaibo
    MODERN PATHOLOGY, 2019, 32
  • [39] Her2 gene status in breast"in situ" and invasive ductal carcinoma
    Cozaru, G. C.
    Mitroi, A. F.
    Aschie, M.
    Brinzan, C. S.
    Poinareanu, I.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 968 - 969
  • [40] HER2 in invasive breast carcinoma: Association with prognostic and predictive factors
    Grazio, Snjezana Frkovic
    Drev, Primoz
    Bracko, Matej
    VIRCHOWS ARCHIV, 2007, 451 (02) : 149 - 149
12345